The introduction of antimicrobial therapy during lower respiratory tract infections can be guided by the implementation of biomarkers (PCT or CRP), and the excessive use of prescribing antibiotics in health care can be decreased. The gene discussed is CRP; the disease is Recurrent lower respiratory tract infections.